FMR1 Testing – Current Technologies and New Advances in CGG Repeat Quantification and Categorization

An educational webinar sponsored by Asuragen, Inc. and the Association for Molecular Pathology (AMP)

Featuring:

Sue Richards, PhD, FACMG
Professor, Molecular & Medical Genetics
Director, Clinical Molecular Genetics
Oregon Health Science University

Objectives of this webinar:

• To gain a comprehensive understanding of the existing approaches for FMR1 testing, including both lab developed tests (LDT’s) and commercial options
• To review challenges and advantages that these offer to a clinical molecular diagnostic lab

For more information, contact Jane Papadaki Markley at jmarkley@asuragen.com

This is part 1 of a 4 part FMR1 educational webinar series sponsored by Asuragen, Inc. & the Association for Molecular Pathology (AMP)

• Webinar #1 – 4.10.2012
  FMR1 testing – current technologies and new advances in CGG repeat quantification and categorization
  Speaker: Sue Richards, PhD, FACMG / Oregon Health Science University
• Webinar #2 – 6.20.2012
  Reclassification of FMR1 expansion risk: The role of AGG Interruptions
  Speaker: Liz Berry-Kravis, MD, PhD / Rush
  Brad Coffee, PhD / Emory University School of Medicine
• Webinar #3 – July 25, 2012
  FMR1 Methylation PCR – eliminating the need for Southern Blot testing
  Speaker: Elaine Lyon, PhD / ARUP Laboratories
• Webinar #4 – September 18, 2012
  FMR1 Carrier Screening – the how, the why, and the when
  Speaker: Brad Coffee, PhD / Emory University School of Medicine